Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
WATCH: What we have learned so far and other thoughts on the new European patent litigation system
Americas
WATCH: What we have learned so far and other thoughts on the new European patent litigation system
The Unified Patent Court (UPC) opened for business in June 2023. In this session, Ravi Srinivasan, partner at JA Kemp, explains how UPC litigation has been shaping up over the past year and shares practical tips based on experiences so far.   24 December 2024
WATCH: Jurisdictional overreach of foreign courts in patent disputes
Americas
WATCH: Jurisdictional overreach of foreign courts in patent disputes
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration.   22 December 2024
WATCH: Revolutionising healthcare – medtech’s impact on patent strategy
Americas
WATCH: Revolutionising healthcare – medtech’s impact on patent strategy
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing.   20 December 2024
Americas
WATCH: Intersectionality of IP with licensing and commercialisation
Speakers from Philips Ormonde Fitzpatrick, Axinn Veltrop & Harkrider, and Leason Ellis discuss how IP rights are not merely legal tools but strategic assets that can significantly influence a product’s lifecycle, from development to market.   19 December 2024
Americas
WATCH: Bridging academia and industry - how can universities and industry work most effectively together?
Speakers from Mammoth Biosciences, Cargo Therapeutics, Star Therapeutics, and Greenberg Traurig, discuss academia and industry, technology transfer, and leveraging research for commercialisation.   19 December 2024
Americas
WATCH: AI and machine learning in drug discovery - patenting AI-generated inventions
Speakers from Akin, Bristol Myers Squibb, Gilead Sciences, and Pfizer discuss how AI accelerates drug discovery, from target identification to predictive modelling, reducing costs and enhancing therapeutic outcomes.   19 December 2024
Americas
Novartis shields eye-drop patent at European Patent Office
Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company’s application.   19 December 2024
Americas
WATCH: What are the latest challenges in patenting biologics, biosimilars, and bispecific antibodies?
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field.   18 December 2024
Americas
WATCH: Beyond the obvious: novelty, non-obviousness, and the inventive step in polymorph patents and beyond
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step.   18 December 2024
Americas
LSPN launches its first-ever US awards to celebrate life sciences leaders
LSIPR’s key event series to host its inaugural ceremony next year in Boston | Spotlight on top innovators and firms in life sciences IP | Gala to honour contributions across 21 categories with 15 judges.   17 December 2024